Archive for category: Firm Announcements

You are here: / Firm Announcements

Cassel Salpeter & Co. Announces Three Promotions

MIAMI – January 26, 2016 – Cassel Salpeter & Co., a middle-market investment banking firm providing merger, acquisition, divestiture and corporate finance services, today announced three promotions: Philip Cassel and Chris Mansueto have been named vice president, and Laura Salpeter has been named associate.

“We are pleased to promote Phil, Chris and Laura as part of our commitment to cultivating the industry’s top talent and continuing to meet a growing client demand for our services,” said James S. Cassel, chairman and co-founder.

Cassel, with experience in consulting and private equity, provides assistance across all areas of the firm, from financial analysis to advisory services. Primarily, he guides clients through M&A and capital raise efforts and supports the firm’s fairness opinion advisory work.

Prior to joining Cassel Salpeter, Cassel worked for Rialto Capital, a real estate private equity fund. He also worked in the Turnaround and Restructuring Group at Alvarez & Marsal. Cassel earned a bachelor’s degree in mathematics from the Massachusetts Institute of Technology, in Cambridge, MA.

Mansueto has extensive experience in the valuation of companies, securities and intangible assets for financial reporting, tax planning, and internal planning
purposes. He has completed purchase price allocations, impairment testing valuations, derivative securities valuations, and equity valuations under complex capital structures.

He has earned the right to use the Chartered Financial Analyst designation offered by the CFA Institute as well as the Accredited Senior Appraiser designation in the area of business valuation offered by the American Society of Appraisers. Mansueto earned a master’s in business administration from Rice University, in Houston, and a bachelor’s degree from George Mason University, in Fairfax, VA.

Salpeter draws on her experience to provide thorough, efficient analysis of complex financial transactions. In this role, she contributes to the firm’s merger and acquisitions, fairness and solvency opinions, restructuring, and financial advisory services.

Salpeter is a member of both The Florida Bar and the District of Columbia Bar. Prior to joining Cassel Salpeter, she worked at Conrad & Scherer and Ephraim Roy Hess. She also clerked at the 17th Judicial Circuit Court of Florida in Broward County for the Honorable Judge Paul Backman. Salpeter received her master’s and bachelor’s degrees from the University of Central Florida, in Orlando, FL, and her Juris Doctor from Nova Southeastern University, in Fort Lauderdale, FL.

About Cassel Salpeter & Co.

Cassel Salpeter & Co. is an independent investment banking firm that provides advice to middle market and emerging growth companies in the U.S. and worldwide. Together, the firm’s professionals have more than 50 years of experience providing private and public companies with a broad spectrum of investment banking and financial advisory services, including: mergers and acquisitions; equity and debt capital raises; fairness and solvency opinions; valuations; and restructurings, such as 363 sales and plans of reorganization. Co-founded by James Cassel and Scott Salpeter, the firm provides objective, unbiased, results-focused services that clients need to achieve their goals. Personally involved at every stage of all engagements, the firm’s senior partners have forged relationships and completed hundreds of transactions and assignments nationwide. The firm’s headquarters are in Miami. Member FINRA and SIPC. More information is available at www.CasselSalpeter.com

Join Us in Celebrating Our Five-Year Anniversary

CasselSalpeter-5YearAnniversary-Header-6.9.15

We are thrilled to celebrate our five-year anniversary and thankful for the support from all our friends, clients, and colleagues that made our success possible. As the market has continued to expand, our firm has enjoyed tremendous growth based on the highly valued investment banking and financial advisory services we provide our clients in middle- and emerging-growth markets. These services include mergers and acquisitions; equity and debt capital raises; fairness and solvency opinions; valuations; and restructurings.

CS-5YearAnniversary-Draft8-6.2.15-v2

Our key achievements include:

  • Completing more than 200 transactions and assignments nationwide – totaling more than $10.8 billion in value – in varied industries, including financial and business services, healthcare, retail, aviation, and technology
  • Growing our professional team by 100 percent
  • Publishing, in partnership with PitchBook Data, the Florida Private Equity Deal Report, a semi-annual, top-level breakdown of private equity in Florida
  • Sharing our firm’s subject-matter expertise and thought leadership in national media outlets such as Bloomberg, The Deal, American Banker and Mergers & Acquisitions Magazine, and local outlets such as Florida Trend and The Miami Herald

Looking ahead at the next five years, we will continue to invest in our business and expand in order to meet a growing demand for the quality investment banking services and advice we are known to provide.

Thank you again for your support – we could not do it without you. Please contact us if we can be of assistance.

Levon Resources Ltd. Announces Definitive Agreement to Acquire SciVac Ltd.

From: Marketwire – Canada

Mar-20-2015 8:30 AM

VANCOUVER, BRITISH COLUMBIA–(Marketwired – March 20, 2015) –
Levon Resources Ltd. (“Levon”) (TSX:LVN)(OTCQX:LVNVF)
(BERLIN:LO9)(FRANKFURT:LO9) and SciVac Ltd. (“SciVac”)
announced today that they have entered into an arrangement
agreement pursuant to which Levon will acquire 100% of the issued
and outstanding ordinary shares of SciVac by way of a court-approved
plan of arrangement (the “Arrangement”).

“I am excited to announce this transaction with SciVac, as I believe
it will generate tremendous value for Levon shareholders,” stated Ron
Tremblay, President and Chief Executive Officer of Levon. “In a difficult
market for resource issuers, we have chosen to preserve capital while
seeking to identify alternatives to create shareholder value. The
acquisition of SciVac gives Levon ownership of Sci-B-Vac(TM), a
commercial stage, potentially best in class hepatitis B vaccine which
could address a significant market opportunity. Levon shareholders will
also maintain an interest in Levon’s existing business and assets by
receiving shares of a newly formed company which will hold Levon’s
existing resource assets.”

Pursuant to the Arrangement, Levon shareholders will receive one new
common share of Levon (each a “New Levon Share”) and 0.5 of a
commonshare (each, a “Spinco Share”) of 1027949 BC Ltd., a newly
formedexploration company (“Spinco”) in exchange for each common
share of Levon (each a “Levon Share”) held by them. Upon closing
of the Arrangement, Levon shareholders will hold 100% of the
issued and understanding Spinco Shares and 31.6% of the issued and
outstanding New Levon Shares, with the former holders of SciVac
Shares holding the remaining 68.4% of the issued and outstanding
New Levon Shares.

In addition to acquiring all of the issued and outstanding shares
of SciVac, Levon will retain CAD $27 million in cash. All other
assets and liabilities of Levon will be transferred to or will be
assumed by Spinco. At the closing of the Arrangement, Levon expects
that in addition to holding all of Levon’s mineral properties,
including Levon’s flagship Cordero Project, SpinCo will have
approximately $20.1M in working capital, including approximately
$3M in cash, a $1.1M convertible debenture as well as 35,178,572
shares of Pershing Gold Corporation with current estimated value
of $16M. SpinCo will also hold a $2M Mexican value added tax
receivable that Levon expects will be recovered. The total of 22.1M
represents approximately 48% of Levon’s working capital as at
December 31, 2014.

“SciVac is pleased to announce this transaction with Levon in furtherance
of our goal of expanding market opportunities for SciVac products in
development, including Sci-B-Vac, our third-generation hepatitis B
vaccine,” said Dr. Curtis Lockshin, Chief Executive Officer for SciVac.
“Sci-B-Vac has already been approved in several countries, including
Israel, where it has been provided to hundreds of thousands of newborn
children. We intend to pursue marketing approvals for Sci-B-Vac in the
United States and other territories worldwide, initially focused on
at-risk populations such as End-Stage Renal Disease and HIV patients.
In addition, we believe the transaction will permit SciVac to cultivate
a pipeline of other therapeutics, utilizing novel treatment approaches
in various disease areas with unmet needs.”

SciVac is currently a privately owned company, of which approximately
45% of the shares are owned by OPKO Health, Inc. (NYSE:OPK).
OPKO’s CEO and Chairman, Dr. Phillip Frost, commented, “This
transaction with Levon presented an opportunity to unlock meaningful
value for OPKO shareholders via OPKO’s ownership interest in SciVac.
SciVac is a commercial-stage biotech leader in protein engineering whose
flagship product, Sci-B-Vac, is a superior next generation hepatitis
B vaccine. Sci-B-Vac has received approval for use in ten countries
including Israel, where it captures half the market for neonatal
hepatitis B vaccinations, and is offered to adults who do not respond
to competing hepatitis B vaccines. It appears positioned to expand
the billion dollar global hepatitis B vaccine market upon successful
completion of the FDA approval process.”

The board of directors of Levon has unanimously approved the
transaction and all directors and officers of Levon, collectively
holding approximately 10.08% of the number of Levon Shares and
76.94% of the number of options to purchase Levon Shares
(the “Levon Options”) anticipated to be entitled to vote at a special
meeting to consider the Arrangement, have agreed to vote in favour
of the Arrangement.

Arrangement Details

The Arrangement will be effected by way of a court-approved plan
of arrangement and will require the approval of at least 2/3 of the
votes cast by Levon’s shareholders and optionholders at a special
meeting expected to take place in April 2015 (the “Meeting”). The
transaction is also subject to applicable regulatory approvals,
including approval of the TSX, and the satisfaction of certain closing
conditions customary in transactions of this nature.

The Arrangement will result, through a series of transactions, in:

—  Levon shareholders receiving one New Levon Share and 0.5 of a
Spinco

Share for each Levon share currently held by them;

—  holders of SciVac Shares receiving that number of New Levon
Shares

representing 68.4% of the issued and outstanding New Levon Shares in

exchange for the acquisition by Levon of all of the issued and

outstanding SciVac Shares;

—  the change of Levon’s name to “SciVac Inc.”; and

—  the change of Spinco’s name to “Levon Resources Ltd.”

Holders of outstanding Levon stock options may exercise their
options until the effective time of the Arrangement, at which time
they will be cancelled.

On completion of the Arrangement, Spinco will own and operate
the existing business of Levon and Levon will own and operate
the existing business of SciVac. Levon shareholders who receive
New Levon Shares and Spinco Shares under the Arrangement will hold
100% of the issued and outstanding Spinco Shares and 31.6% of the
issued and outstanding New Levon Shares, with the former holders
of SciVac Shares holding the remaining 68.4% of the issued and
outstanding New Levon Shares.

After taking into consideration, among other things, the terms of
the Arrangement, the unanimous recommendation of a special committee
of Levon directors established to review the Arrangement and discussions
with its legal and financial advisors, Levon’s board of directors has
unanimously concluded that the Arrangement is in the best interests of
Levon and has approved the Arrangement. Levon’s board of directors
intends to recommend in the management information circular to be mailed
in connection with the Meeting that Levon’s shareholders and optionholders
vote in favour of the Arrangement.

Subject to SciVac’s right to match, Levon’s board of directors may
terminate the arrangement agreement in favour of an unsolicited
superior proposal upon payment of a US$1 million break fee to SciVac.

Advisors

Levon’s legal counsel is Stikeman Elliott LLP and Dorsey &
Whitney LLP. Cassel Salpeter & Co., LLC is Levon’s financial advisor.

About Levon Resources Ltd.

Levon is a gold and precious metals exploration Company, exploring the
company’s 100% owned flagship Cordero bulk tonnage silver, gold, zinc,
and lead project near Hidalgo Del Parral, Chihuahua, Mexico.

About SciVac Ltd.

SciVac Ltd., headquartered in Rehovot Israel, is in the business of
developing, producing and marketing biological products for human
healthcare. SciVac’s flagship product Sci-B-Vac is a recombinant 3rd
generation hepatitis B vaccine. SciVac also offers contract development
and manufacturing services to the life sciences and biotechnology
markets.

ON BEHALF OF THE BOARD

Ron Tremblay, President and Chief Executive Officer

Safe Harbour Statement – This news release contains “forward-looking
information” and “forward-looking statements” (together, the
“forward-looking statements”) within the meaning of applicable
securities laws and the United States Private Securities Litigation
Reform Act of 1995. These forward-looking statements, include,
but are not limited to, statements regarding the completion of
the Arrangement and the various steps thereto, the mailing of
a management information circular in connection with the Meeting and
the holding of the Meeting and are made as of the date of this news
release. Readers are cautioned not to place undue reliance on
forward-looking statements, as there can be no assurance that the
future circumstances, outcomes or results anticipated in or implied
by such forward-looking statements will occur or that plans, intentions
or expectations upon which the forward-looking statements are based
will occur. While we have based these forward-looking statements on our
expectations about future events as at the date that such statements were
prepared, the statements are not a guarantee that such future events
will occur and are subject to risks, uncertainties, assumptions
and other factors which could cause events or outcomes to differ
materially from those expressed or implied by such forward-looking
statements.

Neither the Toronto Stock Exchange (“TSX”) nor its Regulation Services
Provider (as that term is defined in the policies of the TSX)
accepts responsibility for the adequacy or accuracy of this release.
The securities to be issued pursuant to the Arrangement have not been and
will not be registered under the United States Securities Act of 1933, as
amended (the “U.S. Securities Act”) or the securities laws of any state
of the United States and may not be offered or sold absent such
registration or an available exemption from such registration requirements.
The securities in the Arrangement are anticipated to be offered and sold
pursuant to the exemption from registration under Section 3(a)(10) of
the U.S.Securities Act and pursuant to similar exemptions under any
applicable securities laws of any state of the United States. This press
release does not constitute an offer to sell or the solicitation of an
offer to buy any of the securities.

FOR FURTHER INFORMATION PLEASE CONTACT:

Levon Resources Ltd.

Investor Relations

Direct: 604-682-2991

ir@levon.comLevon Resources Ltd.Ron Tremblay

President and Chief Executive Officer

604-682-3701

www.levon.com

Source: Levon Resources Ltd.

 

Reflecting on 2014, Thoughts on 2015
 
“The person who says that it cannot be done should not interrupt the person who is doing it.” 

– Ancient Chinese Proverb

 

At Cassel Salpeter & Co., we have been getting it done for years in the most interesting of times.

Reflecting on 2014, Thoughts for 2015

As 2015 begins, it is important to reflect on the past year, evaluate our performance, and take the necessary steps to ensure that we are best prepared for things to come.

The good news: Things are looking bright on a national level. Despite a volatile stock market and challenging international situations in 2014, we are excited that 2014 helped to position us for a strong 2015. Today, the market is creating opportunities to sell your company or raise capital.

Moreover, in our backyard, Florida continues to gain increasing importance as a hub for investment, deal activity, technology and general business growth. There are many opportunities to take advantage of this resurgent climate and position your business for continued growth.

 

Cassel Salpeter & Co. Celebrates
Another Strong Year

 

For the team at Cassel Salpeter & Co., 2014 was another strong year. Thanks to our valued clients, partners and other friends for continuing to make possible our continued growth and success.

 

Some highlights included:

  • Successfully handled more than 50 assignments in a broad range of industries, including healthcare, financial services, business services, retail, technology, and industrial. Our team worked on behalf of family businesses, financial sponsors, public companies, boards of directors and special committees.
  • Published the Florida PE Deal Report: View of Florida, a semi-annual report recapping PE deal flow in Florida. Click here to view.
  • James Cassel continued to share his subject-matter expertise as a middle-market columnist for The Miami Herald.  He also was featured in a spectrum of local and national media, including: Bloomberg, American Banker, The Deal; Mergers & Acquisitions Magazine, Daily Business Review, and Florida Trend.
Changes in 2015 to Watch That May 
Impact Your Business

There is a high likelihood that changes in 2015 in interest rates, unemployment rates, demand curves, and the prices of oil, real estate, and health care will affect your business in one way or another.

No matter what vertical your business operates in, 2015 presents a strong market for sellers with more buyers than sellers in the market as well as attractive financing options available for buyers. However, it’s important for middle-market business owners to keep a close pulse on these key changes in order to protect their best interest and ensure their businesses are in the strongest position in 2015. As always, it’s important to consult trusted professionals with subject-matter expertise who can help develop the right strategic plans to overcome the obstacles and seize the opportunities.

 

Click here to read James Cassel’s article about this topic, which was published on January 19, 2015, in The Miami Herald.

Contact Cassel Salpeter & Co. Today

At Cassel Salpeter & Co., we are excited about the growing demand for our guidance from middle-market and emerging growth companies in the U.S. and worldwide related to mergers and acquisitions, capital raising, fairness & solvency, valuations, restructurings, and general advisory services.

Please feel free to contact us today to learn more about how we can help you.
 
 
About Cassel Salpeter & Co.   

 

Cassel Salpeter & Co. is an independent investment banking firm that provides advice to middle market and emerging growth companies in the U.S. and worldwide. Together, its professionals have more than 50 years of experience providing private and public companies with a broad spectrum of investment banking and financial advisory services, including: mergers and acquisitions; equity and debt capital raises; fairness and solvency opinions; valuations; and restructurings, such as 363 sales and plans of reorganization.

Co-founded by James Cassel and Scott Salpeter, the firm provides objective, unbiased, results-focused services that clients need to achieve their goals. Personally involved at every stage of all engagements, its senior partners have forged relationships and completed hundreds of transactions and assignments nationwide. The firm’s headquarters are in Miami. Member FINRA and SIPC. More information is available at www.casselsalpeter.com.  
Contact Our Team Members  

Tiger Media Announces Agreement to Acquire Interactive Data, LLC

From: Business Wire

Dec-15-2014 8:00 AM

Publicly traded Media Company to enter U.S. data fusion market
through strategic acquisition

SHANGHAI & ATLANTA–(BUSINESS WIRE)–
Tiger Media, Inc. (“Tiger Media” or the “Company”) (NYSE MKT: IDI), a
Shanghai-based multi-platform media company, today announced that it has
entered into a definitive agreement to acquire The Best One, Inc.
(“TBO”), parent company of U.S.-based data solutions provider
Interactive Data, LLC (“Interactive Data”) (the “Acquisition”).
Interactive Data is headquartered in Atlanta, GA and has its primary
technology office in Seattle, WA.

Interactive Data’s recently expanded management team has been executing
on an aggressive growth plan in a multi-billion dollar market of risk
management and marketing data solutions. The Acquisition will give the
integrated company a strong foothold in the data fusion industry with a
management team that has helped mold the entire sector.

“As a founding shareholder of Tiger Media, Inc., I am enthusiastic to
enter into the rapidly growing, multi-billion dollar industry of data
fusion,” said Dr. Phillip Frost, CEO and Chairman of OPKO Health, Inc.
(NYSE:OPK), and Tiger Media’s largest beneficial owner. “The
impressive track record of TBO’s management team in building the
dominant companies in this industry speaks for itself, and I believe
this will be a major player in the space.”

Commenting on the Acquisition, Robert Fried, Chairman of Tiger Media
stated, “We are excited to acquire TBO. We were looking for a U.S.
partner who would also be able to expand our China operations. We
believe this Acquisition with TBO will give our shareholders an
excellent opportunity to realize increased value on their investment.”

TBO’s executive leadership represents over half a century of combined
experience in the industry and is led by Chairman Michael Brauser. An
investor and operator in the data fusion market since its infancy, Mr.
Brauser has built market leading companies with revenues totaling over
$2 billion.

Chief Scientific Officer of TBO, Ole Poulsen, was primary systems
architect of the data fusion industry’s leading products. The products
that Mr. Poulsen designed led to the sales of multiple companies
totaling over $1 billion in the aggregate.

Under the terms of the merger agreement, current shareholders of Tiger
Media and TBO will own approximately 34% and 66% of the combined
company, respectively, following the Acquisition. Approximately 65% of
the shares to be issued to TBO shareholders in the Acquisition will be
non-voting preferred stock, and 30% of those shares will only be issued
upon achievement of certain revenue targets. The Acquisition is expected
to close in the first quarter of 2015, is subject to customary
conditions to closing as detailed in the merger agreement, as well as
the affirmative vote of a majority of the outstanding shares of Tiger
Media entitled to vote.

In connection with the Acquisition, Tiger Media will be redomesticating
as a Delaware company. The affirmative vote of 2/3 of the votes cast at
the Tiger Media meeting will be required for domestication in Delaware.
The structure of the transaction will be in the form of an acquisition
with TBO merging into a wholly-owned subsidiary of Tiger Media, with the
Tiger Media subsidiary as the surviving corporation that will now be
headquartered in Atlanta, GA.

Following the Acquisition, Derek Dubner, CEO of TBO, will join Tiger
Media as Co-CEO along with Peter Tan, current CEO of Tiger Media. Robert
Fried will remain Chairman of the Board. Also, following the
Acquisition, Derek Dubner and Daniel MacLachlan will join the Tiger
Media Board, increasing the Tiger Media Board from five members to seven
members.

Cassel Salpeter is acting as financial advisor and Akerman LLP is acting as legal counsel to Tiger Media. Nason Yeager is acting as legal counsel to TBO.

About Tiger Media, Inc.

Tiger Media is a leading Shanghai-based multi-platform media company in
China which provides advertising services in the out-of-home advertising
industry, including iScreen Outdoor LCD screens, billboards and street
furniture. Tiger Media’s network of street level LCD screen displays,
which captivate eye-level awareness, is complemented by outdoor
billboards which are mostly built on rooftops with good visibility from
far distances. Tiger Media’s network attracts advertising clients from a
wide range of industries including telecommunications, insurance and
banking, automobile, electronics and fast moving consumer goods. Learn
more at www.tigermedia.com.

About Interactive Data, LLC
Interactive Data is a data solutions provider, historically delivering
data products and services to the Accounts Receivable Management (ARM)
industry for location and identity verification, legislative compliance
and debt recovery for over a decade. Interactive Data has served a niche
segment of the risk management industry, consisting of collection
agencies, collection law firms, and debt buyers. Interactive Data has
recently expanded the executive leadership team, adding significant
industry experience. Immediate capital infusion drives an enhancement
and broadening of current offerings as well as expansion into new
markets and services. Learn more at www.id-info.com.

FORWARD LOOKING STATEMENTS
This press release contains “forward-looking statements,” as that term
is defined under the Private Securities Litigation Reform Act of 1995
(PSLRA), which statements may be identified by words such as “expects,”
“plans,” “projects,” “will,” “may,” “anticipate,” “believes,” “should,”
“intends,” “estimates,” and other words of similar meaning. Such forward
looking statements include statements about the anticipated benefits of
combining Tiger Media and TBO, expectations for closing the Acquisition,
as well as other non-historical statements about our expectations,
beliefs or intentions regarding our business, technologies and products,
financial condition, strategies or prospects. There are a number of
important factors that could cause actual results or events to differ
materially from those indicated by such forward-looking statements,
including: the ability of each of Tiger Media and TBO to satisfy the
closing conditions and consummate the transaction, including Tiger Media
obtaining the required shareholder approvals; the risk that the business
of TBO may not be integrated successfully; the risk that the transaction
may involve unexpected costs or unexpected liabilities; the risk that
synergies from the transaction may not be fully realized or may take
longer to realize than expected; and the other risks set forth in Tiger
Media’s Annual Report on Form 20-F, filed with the SEC on March 31,
2014, as well as the other factors described in the filings that Tiger
Media makes with the SEC from time to time.
The forward-looking statements contained in this press release speak
only as of the date the statements were made, and we do not undertake
any obligation to update forward-looking statements, except as required
under applicable law. We intend that all forward-looking statements be
subject to the safe-harbor provisions of the PSLRA.

ADDITIONAL INFORMATION AND WHERE TO FIND IT
This communication does not constitute an offer to sell or the
solicitation of an offer to buy any securities or a solicitation of any
vote or approval nor shall there be any sale of securities in any
jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any
such jurisdiction. In connection with the proposed Acquisition, Tiger
Media will file with the Securities and Exchange Commission (the “SEC”)
a proxy statement in connection with a Special Meeting of its
shareholders. SHAREHOLDERS OF TIGER MEDIA ARE URGED TO READ THE PROXY
STATEMENT REGARDING THE PROPOSED TRANSACTION WHEN IT BECOMES AVAILABLE,
AS WELL AS OTHER DOCUMENTS FILED WITH THE SEC, BECAUSE THEY WILL CONTAIN
IMPORTANT INFORMATION. Shareholders of Tiger Media will be able to
obtain a copy of the proxy statement, as well as other filings
containing information about Tiger Media and TBO, without charge, at the
SEC’s website (www.sec.gov).
Shareholders of Tiger Media may also obtain copies of all documents
filed with the SEC, without charge, by directing a request to Tiger
Media, Inc., ir@tigermedia.com.

PARTICIPANTS IN THE MERGER SOLICITATION

Tiger Media and its directors, executive officers and other members of
management and employees may be deemed to be participants in the
solicitation of proxies from Tiger Media shareholders in connection with
the proposed transaction. Information regarding the persons who may,
under the rules of the SEC, be deemed participants in the solicitation
of Tiger Media’s shareholders in connection with the proposed
transaction will be set forth in the proxy statement when it is filed
with the SEC. Also, information about Tiger Media’s directors and
executive officers is set forth in its Notice for Annual General Meeting
of Shareholders, which was filed with the SEC on November 19, 2014, and
its Annual Report on Form 20-F for the year ended December 31, 2013,
filed with the SEC on March 31, 2014, respectively. These documents are
available free of charge at the SEC’s website at www.sec.gov,
or by going to Tiger Media’s Investor Relations page on its corporate
website at www.tigermedia.com.

Cassel Salpeter & Co. Represents DynaVox in $18 Million Sale

MIAMI – June 12, 2014 – Cassel Salpeter & Co., a middle-market investment banking firm providing merger, acquisition, divestiture and corporate finance services, represented DynaVox Inc. (OTCPK: DVOX.Q), debtor-in-possession, in connection with a Section 363 sale transaction approved by the Delaware Bankruptcy Court to Tobii Technology AB, a Swedish technology company with offices worldwide.  In a competitive auction on May 21, Tobii was the successful bidder for substantially all of the operating assets of DynaVox with its $18 million bid.  The transaction closed on May 23.

Tobii expects the purchase of DynaVox to solidify the position of its assistive technology division as the international leader in the augmentative and alternative communication and accessibility markets.  DynaVox, with headquarters in Pittsburgh, provides speech-generating devices and symbol-adapted special education software to help people overcome speech, language, and learning challenges.

Cassel Salpeter advised DynaVox in completing the sale in an expedited three-week time frame and provided assistance throughout all phases of the sales process, due diligence, and auction.

“We are pleased to have successfully represented our client in this complex sale in a tight timeframe,” said James Cassel, co-founder and chairman of Cassel Salpeter, who led the assignment along with Philip Cassel, an associate with the firm.

Added DynaVox’s bankruptcy counsel Paul J. Battista:  “The sale was a great success in that it assures all creditors will be paid in full and money will be available to be distributed to shareholders.  Jim and his team jumped into the process, came up to speed quickly and were invaluable in helping generate this great result.”

Tobii is noted as a global market leader in eye tracking and a pioneer in gaze interaction. Its products are widely used for communications by people with disabilities. They are also used within the scientific community and in commercial market research and usability studies.

The debtors were represented by Paul Battista and Heather Harmon, partners with Genovese Joblove & Battista, P.A., and William Chipman, Jr., partner, and Mark Olivere, counsel, with Cousins Chipman & Brown, LLP.

About Cassel Salpeter & Co.

Cassel Salpeter & Co. is an independent investment banking firm that provides advice to middle market and emerging growth companies in the U.S. and worldwide. Together, the firm’s professionals have more than 50 years of experience providing private and public companies with a broad spectrum of investment banking and financial advisory services, including: mergers and acquisitions; equity and debt capital raises; fairness and solvency opinions; valuations; and restructurings, such as 363 sales and plans of reorganization. Co-founded by James Cassel and Scott Salpeter, the firm provides objective, unbiased, results-focused services that clients need to achieve their goals. Personally involved at every stage of all engagements, the firm’s senior partners have forged relationships and completed hundreds of transactions and assignments nationwide. The firm’s headquarters are in Miami. Member FINRA and SIPC.

Cassel Salpeter & Co. Secures Senior Debt Financing for IPR International, LLC

MIAMI — March 10, 2014 — Cassel Salpeter & Co., LLC, a middle-market investment banking firm providing merger, acquisition, divestiture and corporate finance services, represented IPR International, LLC,  in securing senior debt financing from Elm Park Capital Management, a private credit-focused investment firm. The financing will support numerous growth initiatives.

IPR, with headquarters outside Philadelphia, is a recognized industry leader offering private cloud and infrastructure as service solutions, cloud-based data protection and management services, and a complete range of managed solutions.

Cassel Salpeter advised IPR in evaluating its financing alternatives and provided assistance throughout the due diligence and closing process. Cassel Salpeter Director Joseph “Joey” Smith and Vice President Marcus Wai led the assignment. Smith and Wai have decades of experience helping quality, middle-market businesses raise capital and complete mergers and acquisitions.

IPR’s Chief Executive Officer Tami Fratis said: “The support provided by Cassel Salpeter reflects its confidence in our business and its future growth. Cassel Salpeter provided professional, high-quality assistance throughout all phases of the transaction, and we look forward to continuing our relationship as our business grows.”

About Cassel Salpeter & Co.

Cassel Salpeter & Co. is an independent investment banking firm that provides advice to middle market and emerging growth companies in the U.S. and worldwide. Together, the firm’s professionals have more than 50 years of experience providing private and public companies with a broad spectrum of investment banking and financial advisory services, including: mergers and acquisitions; equity and debt capital raises; fairness and solvency opinions; valuations; and restructurings, such as 363 sales and plans of reorganization. Co-founded by James Cassel and Scott Salpeter, the firm provides objective, unbiased, results-focused services that clients need to achieve their goals. Personally involved at every stage of all engagements, the firm’s senior partners have forged relationships and completed hundreds of transactions and assignments nationwide. The firm’s headquarters are in Miami. Member FINRA and SIPC. More information is available at www.CasselSalpeter.com

About IPR International

IPR International is a recognized industry leader offering private cloud and infrastructure as a service solutions, as well as colo services and a full range of private cloud managed service offerings like virtual private data centers, storage as a service, network as a service and disaster recovery as a service. Through its comprehensive suite of services, protects, preserves, secures and makes available its clients’ data at all times, no matter when or where the data was created and no matter when or where it is needed.  Through its constantly innovative and evolving services, combined with a passion for security, integrity, availability and ingenuity, IPR helps its clients maintain their own business operations and supports them through any interruptions.  IPR has multiple redundant data centers and serves clients in 25 countries worldwide. For more information on IPR International, visit www.IPRsecure.com

Frederick’s of Hollywood Group Inc. Enters Definitive Agreement for “Going Private” Transaction

HOLLYWOOD, Calif., Dec. 19, 2013 /PRNewswire/ — Frederick’s of Hollywood Group Inc. (OTCQB: FOHL) (the “Company”) announced that it has entered into a definitive merger agreement that provides for the acquisition of the Company by a group consisting of HGI Funding LLC, a wholly owned subsidiary of Harbinger Group Inc., and certain of the Company’s other common and preferred shareholders (the “Consortium”). The members of the Consortium as a group beneficially own approximately 88.6% of the Company’s common stock. The acquisition will be accomplished through FOHG Holdings, LLC (“Holdings”), an entity controlled by the Consortium that was formed for the purpose of the transaction.

Under the merger agreement, the Company’s shareholders who are not members of the Consortium will receive $0.27 per share in cash upon completion of the transaction. The price represents a premium of 50% to the closing price of the Company’s shares onSeptember 27, 2013, the last trading day before the announcement by the Consortium of its proposal, and a premium of 46% over the average closing price of the Company’s common stock for the 45 trading days prior to that date.

The Company’s board of directors delegated to its lead independent, disinterested director the authority to review the initial transaction proposal from, and negotiate terms of the proposal with, the Consortium, with the assistance of legal and financial advisors. The lead director completed a thorough review of the proposal, considered alternatives, negotiated improved terms of the Consortium’s proposal and concluded that the transaction with the Consortium was fair to and in the best interests of the Company’s shareholders other than the members of the Consortium. Based on the recommendation of the lead director, the merger agreement was also approved by the full board other than William Harley and Thomas Lynch, who recused themselves from the deliberations.

In addition, in connection with the execution of the merger agreement, the Company and Holdings entered into a new employment agreement with Thomas Lynch, chief executive officer of the Company, which will take effect only upon the consummation of the merger. Under the new employment agreement, Mr. Lynch agreed to continue to serve as chief executive officer for three years following the merger.

Completion of the transaction is subject to certain customary conditions, including receipt of shareholder approval. The merger agreement must be approved by the affirmative vote of the holders of at least two-thirds of all outstanding shares of the Company’s common stock. If completed, the transaction will result in the Company becoming privately-held and its common stock will no longer be quoted on the OTCQB.

Further details concerning the merger agreement and related documents, including the employment agreement with Mr. Lynch, will be described in a Current Report on Form 8-K to be filed by the Company with the Securities and Exchange Commission.

Cassel Salpeter & Co., LLC is acting as financial advisor to the lead director in connection with the transaction. Graubard Miller is acting as legal advisor to the Company. Milbank, Tweed, Hadley & McCloy LLP is acting as legal advisor to HGI Funding LLC.

Additional Information and Where to Find It

In connection with the transaction, the Company will file a proxy statement with the SEC. Shareholders are advised to read the proxy statement when it is available because it will contain important information. Shareholders will be able to obtain a free copy of the proxy statement when available and other relevant documents filed with the SEC from the SEC’s website at www.sec.gov, or by directing a request by mail to Frederick’s of Hollywood Group Inc., 6255 Sunset Boulevard, Hollywood, CA 90028, or from the Company’s corporate website at www.fohgroup.com.

The Company and certain of its directors and officers may, under the rules of the SEC, be deemed to be “participants” in the solicitation of proxies from its shareholders that will occur in connection with the transaction. Information concerning the interests of the persons who may be considered “participants” in the solicitation is set forth in the Company’s proxy statements and its Annual Report on Form 10-K, as amended by its Form 10-K/A, previously filed with the SEC, and will be set forth in the proxy statement relating to the transaction when the proxy statement becomes available. Copies of these documents can be obtained, without charge, at the SEC’s website at www.sec.gov, by directing a request to the Company at the address above, or from the Company’s corporate website at www.fohgroup.com.

Forward Looking Statement

Certain of the matters set forth in this press release are forward-looking and involve a number of risks and uncertainties.  These statements are based on management’s current expectations or beliefs.  Actual results may vary materially from those expressed or implied by the statements herein.  Among the factors that could cause actual results to differ materially are the following: competition; business conditions and industry growth; rapidly changing consumer preferences and trends; general economic conditions; working capital needs; continued compliance with government regulations; loss of key personnel; labor practices; product development; management of growth, increases in costs of operations or inability to meet efficiency or cost reduction objectives; timing of orders and deliveries of products; risks of doing business abroad; the ability to protect our intellectual property; satisfaction of the various conditions to the closing of the transaction contemplated by the merger agreement; and the other risks that are described from time to time in the Company’s SEC reports.  The Company is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise.

About Frederick’s of Hollywood Group Inc.

Frederick’s of Hollywood Group Inc., through its subsidiaries, sells women’s apparel and related products under its proprietary Frederick’s of Hollywood® brand through 112 specialty retail stores, a catalog and an online shop at http://www.fredericks.com/.  With its exclusive product offerings including Seduction by Frederick’s of Hollywood and the Hollywood Exxtreme Cleavage® bra, Frederick’s of Hollywood is the Original Sex Symbol®.

Our press releases and financial reports can be accessed on our corporate website at http://www.fohgroup.com.

This release is available on the KCSA Strategic Communications Web site at http://www.kcsa.com.

Bioheart, Inc. Enters Into Investment Banking Agreement With Cassel Salpeter & Co.

Leading National Independent Investment Banking Firm to Support Bioheart With Raising Capital Among Other Activities

MIAMI — Dec. 23, 2013 — Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development, and commercialization of autologous cell therapies, has entered into an investment banking agreement with Cassel Salpeter & Co. as its exclusive financial advisor in connection with investment banking matters. Among other activities as part of the 24-month agreement, Cassel Salpeter will help Bioheart raise capital.

“Bioheart has great potential and technology that can be commercialized with the right partners and capital,” said James Cassel, chairman and co-founder of Cassel Salpeter, a national independent investment banking firm that provides advisory services to middle-market and emerging growth companies. “We look forward to helping the Bioheart team identify and evaluate various financial opportunities and strategic relationships.”

Bioheart has been treating patients with cell therapy since 2001 and continues to lead the field with ground breaking trials and results. Bioheart’s MyoCell therapy has been successfully administered to hundreds of patients. Bioheart is the first company to receive clearance from the FDA for a Phase I study (REGEN trial) using a combined cell and gene therapy product (MyoCell-SDF-1). In addition, Bioheart has successfully utilized adipose derived stem cells in a variety of indications since 2006.

“Cassel Salpeter’s team has an impressive track record spanning more than 50 years that includes successfully handling numerous capital-raising transactions and providing advisory services to companies in a full spectrum of industries,” said Mike Tomas, Bioheart’s president and CEO. “The firm also has extensive knowledge of Florida’s entrepreneurship ecosystem and has assisted many small and middle-market public companies in the state.”

About Cassel Salpeter & Co.

Cassel Salpeter & Co. is an independent investment banking firm that provides advice to middle-market and emerging growth companies in the U.S. and worldwide. Together, the firm’s professionals have more than 50 years of experience providing private and public companies with a broad spectrum of investment banking and financial advisory services, including: mergers and acquisitions; equity and debt capital raises; fairness and solvency opinions; valuations; and restructurings, such as 363 sales and plans of reorganization. Co-founded by James Cassel and Scott Salpeter, the firm provides objective, unbiased, results-focused services that clients need to achieve their goals. For more information, visit www.casselsalpeter.com. Member SIPC & FINRA.

About Bioheart Inc.

Bioheart Inc. is committed to maintaining its leading position within the cardiovascular sector of the cell technology industry delivering cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. Bioheart’s goals are to cause damaged tissue to be regenerated, when possible, and to improve a patient’s quality of life and reduce health care costs and hospitalizations.

Specific to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Its leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient’s heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients. For more information on Bioheart, visitwww.bioheartinc.com, or visit us on Facebook: Bioheart and Twitter @BioheartInc.

SafeStitch Medical Announces Definitive Agreement to Merge with TransEnterix

SafeStitch Medical, Inc. (OTCBB: SFES), today announced that it has entered into a definitive agreement to merge with TransEnterix, Inc., a privately-held, medical device company with advanced technology in the use of flexible devices and robotics for minimally invasive surgery.

Commenting on the merger, Dr. Jane Hsiao, Chairwoman of SafeStitch Medical stated, “We are excited about the breadth of the management team of TransEnterix. There are compelling advantages to innovative flexible technologies and robotics for less invasive surgical interventions, such as our proprietary trans-oral device. This merger will provide greater resources to help bring the pipeline products of the combined company to market and offer our shareholders an excellent opportunity to realize significant value of their investment.”

Todd M. Pope, the existing Chief Executive Officer of TransEnterix, will become the Chief Executive Officer and a Director of the combined company. Paul LaViolette, the current Chairman of TransEnterix, will serve as Chairman of the combined company’s Board of Directors. Dr. Jane Hsiao, the current Chairwoman of SafeStitch Medical will remain a Director, and Dr. Phillip Frost, Chief Executive Officer and Chairman of OPKO Health, Inc. will join as a Director.

Mr. Pope echoed the comments, “We believe this merger will significantly enhance our ability to bring our innovative robotic surgery platform to market. Drs. Frost and Hsiao have a proven track record of driving healthcare innovation while creating significant value for shareholders. We expect the company will be at the forefront of advancements in minimally invasive surgery.”

Under the terms of the merger agreement, current shareholders of SafeStitch Medical and TransEnterix will own approximately 35% and 65% of the combined company, respectively. The Merger is expected to close in the 2013 third quarter, and is subject to customary conditions to closing as detailed in the Merger Agreement. The structure of the transaction will be in the form of a reverse triangular merger with SafeStitch Medical as the surviving corporation and will now be headquartered in the Research Triangle, North Carolina. The combined company will continue to trade on the OTCBB under the symbol SFES initially.

Perella Weinberg Partners is acting as financial advisor and Wilson Sonsini Goodrich & Rosati is acting as legal counsel to TransEnterix. Cassel Salpeter is acting as financial advisor and Greenberg Traurig is acting as legal counsel to SafeStitch Medical.

About SafeStitch Medical

Miami, Florida-based SafeStitch Medical, Inc. is a publicly traded medical device company founded in 2006. Our mission is to develop and market the best in class disposable medical devices to advance minimally invasive surgery for hernia repair, treatment of obesity and other gastroesophageal disorders. SafeStitch Medical has developed and obtained FDA approval to market the AMID Hernia Fixation Device (HFD) for both inguinal and ventral hernia repairs. The AMID HFD allows for faster mesh manipulation, mesh fixation and skin closure.

About TransEnterix

TransEnterix is a development stage medical device company that is pioneering the use of flexible instruments and robotics to improve how minimally invasive surgery is performed. TransEnterix is focused on the development and commercialization of a novel robotic-assisted surgical system.

This press release contains “forward-looking statements,” as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipate,” “believes,” “should,” “intends,” “estimates,” and other words of similar meaning, including statements regarding our product development and commercialization efforts, benefits of combining TransEnterix and SafeStich Medical, expectations for closing the merger, and our ability to significantly improve clinical outcomes in patients, as well as other non-historical statements about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects. Many factors, including those described herein and in our filings with the SEC, could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include, but are not limited to: whether the merger between SafeStitch Medical and TransEnterix will be successful; whether the merger will provide greater resources to help bring the combined company’s pipeline of products, including TransEnterix’s robotic surgery platform, to market; whether the merger will provide shareholders with an excellent opportunity to realize significant value in their investment; whether Drs. Frost and Hsiao’s track record of providing healthcare innovation will create significant value for shareholders and whether that combined company will be at the forefront of advancements in minimally invasive surgery. The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.